Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-130390
Filing Date
2015-04-15
Accepted
2015-04-15 09:00:41
Documents
12
Period of Report
2015-05-22
Effectiveness Date
2015-04-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d867354ddef14a.htm DEF 14A 1393539
2 GRAPHIC g867354g06g32.jpg GRAPHIC 8771
3 GRAPHIC g867354g17u52.jpg GRAPHIC 12025
4 GRAPHIC g867354g25b38.jpg GRAPHIC 15706
5 GRAPHIC g867354g48j77.jpg GRAPHIC 101415
6 GRAPHIC g867354g60j47.jpg GRAPHIC 77378
7 GRAPHIC g867354g72r19.jpg GRAPHIC 11696
8 GRAPHIC g867354g76m95.jpg GRAPHIC 55685
9 GRAPHIC g867354g76x15.jpg GRAPHIC 11277
10 GRAPHIC g867354g88f37.jpg GRAPHIC 14106
11 GRAPHIC g867354g92p31.jpg GRAPHIC 72412
12 GRAPHIC g867354g95p98.jpg GRAPHIC 16652
  Complete submission text file 0001193125-15-130390.txt   1943465
Mailing Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26224 | Film No.: 15770653
SIC: 3826 Laboratory Analytical Instruments